Izuralimab

Modify Date: 2025-08-27 00:35:50

Izuralimab Structure
Izuralimab structure
Common Name Izuralimab
CAS Number 2329669-80-7 Molecular Weight N/A
Density N/A Boiling Point N/A
Molecular Formula N/A Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Izuralimab


Izuralimab is a bispecific IgG1 antibody targeting inducible T-cell costimulator (ICOS/CD278) and PD-1[1].

 Names

Name Izuralimab

 Izuralimab Biological Activity

Description Izuralimab is a bispecific IgG1 antibody targeting inducible T-cell costimulator (ICOS/CD278) and PD-1[1].
Related Catalog
Target

ICOS/CD278, PD-1[1]

References

[1]. Aghanejad A, et al. A review on targeting tumor microenvironment: The main paradigm shift in the mAb-based immunotherapy of solid tumors. Int J Biol Macromol. 2022 May 15;207:592-610.  

 Chemical & Physical Properties

No Any Chemical & Physical Properties
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.